Incyte Corporation

Vicki S Elliott

Henry Yue

Mariah R Baughn

April J A Hafalia

Monique G Yao

Ameena R Gandhi

Yan Lu

Craig H Ison

Anita Swarnakar

Danniel B Nguyen

Rajagopal Gururajan

Neil Burford

Li Ding

Narinder K Chawla

Michael B Thornton

Olga Bandman

Preeti G Lal

Y Tom Tang

Ernestine A Lee

Dyung Aina M Lu

Bridget A Warren

Ian J Forsythe

Chandra S Arvizu

Junming Yang

Brendan M Duggan

Yuming Xu

Catherine M Tribouley

Wen Luo

Pei Jin

Reena Khare

Thomas W Richardson

Joseph P Marquis

Shanya D Becha

Jayalaxmi Ramkumar

Soo Yeun Lee

Uyen K Tran

Joana X Li

Amy D Wilson

Kavitha Thangavelu

Narinder K Chawla-Walia

Janice K Au-Young

Bao M Tran

Kimberly J Gietzen

Madhusudan M Sanjanwala

Michael Thorton

Cynthia D Honchell

Sally Lee

Farrah A Khan

Stephanie K Sapperstein

Liam Kearney

Yalda Azimzai

Angelo M Delegeane

Roopa M Reddy

Gregory Marcus

Jennifer L Policky

Debopriya Das

John D Burrill

Kurt A Zingler

Preeti G Lai

Jennifer A Griffin

Stephen Todd

Deborah A Kallick

Mark L Borowsky

Roberto Hernandez

Various embodiments of the invention provide human kinases and phosphatases (KPP) polypeptides and polynucleotides which identify and encode KPP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KPP.

Antibodies to human &#x3b2;-adrenergic receptor kinase

The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.

Secreted proteins

Human &#x3b2;-adrenergic receptor kinase polypeptide and methods

Various embodiments of the invention provide human kinases and phosphatases (KPP) and polynucleotides which identify and encode KPP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KPP.

Human &#x3b2;-adrenergic receptor kinase nucleic acid molecule

The invention provides human human kinases (PKIN) and polynucleotides which identify and encode PKIN. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PKIN.

Human cAMP-dependent protein kinase beta-catalytic subunit

The invention provides human kinases and phosphatases (KAP) and polnucleotides which identify and encode KAP. The invention also provides expresson vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KAP.

Human protein phosphatase 2C

The invention provides a human cysteine proteases and polynucleotides which encode those proteases. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists, as well as methods for diagnosing, treating, or preventing disorders associated with aberrant expression of cysteine proteases.

Proteases

Growing community of inventors

San Jose, CA, United States of America

Vicki S Elliott